Pharma in Focus - knowledge is power

20 - 26 May 2013

Special Report: PBS now a completely different story
Last week's Budget may have revealed a $2.6 billion downward revision in PBS spending forecasts but it is the changed relationship between PBS spending and GDP that shows a tired 'sustainability' story no longer applies

Budget a speed-bump on PBS highway
The flurry of proposals for radical PBS reform that took place in the months leading up to last week's 2013-14 Budget was ignored by the government, meaning it's back to the drawing board for proponents of NZ-style pricing for Australia

How to access Pharma in Focus articles

If you're a current subscriber, See below
If you're new to Pharma in Focus, Click here
If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

PBS: 20-year listings low, $18b cuts
..full report

PBS plunges as per cent of GDP
..full report

Aust drug R&D 'embarrassing'
..full report

'Ban codeine' an over-reaction
..full report

'Inconsistency' hurt Generic Health
..full report

Call to end trial cost inequity
..full report

Pharma mergers to increase: PwC
..full report

Reckitt, GSK in kiddie bottle battle
..full report

Latest trials: ASCO, rotavirus vax
..full report

Latest ARTG registrations
..full report